Company Overview

National HealthCare Corporation operates, manages, and provides services to skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and a behavioral health hospital. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. The company's medical specialty units comprise memory care units and sub-cute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living centers offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. It also offers behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, it provides health care programs that offer skilled services, such as infusion, wound care and physical, occupational, and speech therapies; hospice care services; operates pharmacies; offers management, accounting, financial, and insurance services; and leases its properties to third party operators. As of February 18, 2022, the company operated 75 skilled nursing facilities with 9,473 beds, 24 assisted living facilities, five independent living facilities, one behavioral health hospital, 34 homecare agencies, and 28 hospice agencies. National HealthCare Corporation was founded in 1971 and is based in Murfreesboro, Tennessee.

  • Name

    National HealthCare Corporation

  • CEO

    Stephen Fowler Flatt

  • Website

    www.nhccare.com

  • Sector

    Health Care Providers and Services

  • Year Founded

    1971

Company Statistics

Profile

  • Market Cap

  • EV

  • Shares Out

  • Revenue

  • Employees

Margins

  • Gross

  • EBITDA

  • Operating

  • Pre-Tax

  • Net

  • FCF

Returns (5Yr Avg)

  • ROA

  • ROTA

  • ROE

  • ROCE

  • ROIC

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

  • Net Debt

  • Debt/Equity

  • EBIT/Interest

Growth (CAGR)

  • Rev 3Yr

  • Rev 5Yr

  • Rev 10Yr

  • Dil EPS 3Yr

  • Dil EPS 5Yr

  • Dil EPS 10Yr

  • Rev Fwd 2Yr

  • EBITDA Fwd 2Yr

  • EPS Fwd 2Yr

  • EPS LT Growth Est

Dividends

  • Yield

  • Payout

  • DPS

  • DPS Growth 3Yr

  • DPS Growth 5Yr

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

What's happening

Nov 12, 2025 - Dec 12, 2025

National Healthcare Corp Navigates Challenges While Outperforming Market

  • NHC's partnership with Mountain View KSA raised concerns about logistics risks despite substantial investments.
  • Insider selling by Director Hassan Emil E triggered negative market reactions among investors.
  • Operational improvements and strong governance practices helped sustain investor confidence throughout the month.

Over the past month, National Healthcare Corp (NHC) demonstrated a stock movement of 2.9%, significantly outperforming the S&P 500's return of 0.7% by an impressive margin of 2.2%. The company's performance also exceeded that of the Health Care sector by 1.0%. This upward trend was supported by key developments in operational growth and cost reductions, which were detailed in a recent report, although there was a noted decline in earnings.

However, challenges arose during this period as bearish sentiment followed NHC's announcement regarding its partnership with Mountain View KSA at the Cityscape Global Exhibition on November 17th. This project involves over $600 million in investments for residential units in Riyadh but has raised concerns about logistical risks related to coal production and EBITDA targets for fiscal year 2026, despite improved sales figures.

On November 13th, NHC faced additional scrutiny when Director Hassan Emil E sold 5,500 shares at $133 each just before reporting operational highlights. Such insider selling often raises apprehension among investors regarding future company performance or leadership confidence levels.

Despite these setbacks, positive momentum continued as NHC reported significant operational achievements towards the end of this period on November 20th. The company's emphasis on enhancing efficiency through effective cost management resonated well with investors seeking stability amid fluctuating earnings reports.

Overall market conditions favored NHC’s performance relative to broader indices like the S&P 500 during this timeframe while maintaining solid governance practices and operational improvements throughout most of the month.

NYSEAM:NHC